NEW YORK (GenomeWeb) – Alere today announced it will pay $13 million to the US Securities and Exchange Commission, ending an investigation by the agency into certain accounting practices by the company's foreign subsidiaries.

In addition to the $13 million settlement, Alere also consented to an administrative cease-and-desist order without admitting or denying the findings of an investigation by the SEC.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.

A new report has found that researchers in Africa are still heavily dependent on funding from organizations in the US, Europe, and China, Nature News says.

An article in The Atlantic argues that the progress being made in science isn't keeping pace with the money and time being spent on research.

In Science this week: a CRISPR screen identifies sideroflexin 1 as a requisite component of one-carbon metabolism, and more.